Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,800
Closed -$300K 6527
2022
Q3
$300K Buy
10,800
+800
+8% +$26K ﹤0.01% 5360
2022
Q2
$296K Hold
10,000
﹤0.01% 5383
2022
Q1
$408K Buy
+10,000
New +$429K ﹤0.01% 5277
2018
Q4
Sell
-100,000
Closed -$3.93M 3703
2018
Q3
$3.93M Buy
+100,000
New +$4.51M ﹤0.01% 1981

Other funds holding ADNT

Israel Englander's ADNT Position: Q2 2026 in Review

Israel Englander increased its Adient (ADNT) stake by 53% in Q2 2026, buying an estimated $2.11M and bringing the position to 284,735 shares worth $5.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2961.

Israel Englander first reported a position in ADNT in Q4 2016 and has held it in 37 quarters since. The position peaked at $26.3M in Q4 2016. 312 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Israel Englander held 284,735 shares of Adient worth $5.23M as of Q2 2026.
  • Israel Englander bought 98,607 Adient shares in Q2 2026, an estimated $2.11M.
  • Adient made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2961 holding.
  • Israel Englander first reported a position in Adient in Q4 2016 and has held it in 37 quarters since.
  • Israel Englander's Adient position peaked at $26.3M in Q4 2016.
  • 312 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.